Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Takeichi T et al. Darier's Disease Complicated by Schizophrenia Caused by a Novel ATP2A2 Mutation. 2016 Acta Derm. Venereol. pmid:27025976
Nomura T et al. Punctate palmoplantar keratoderma type 1: a novel AAGAB mutation and efficacy of etretinate. 2015 Acta Derm. Venereol. pmid:24573067
Ortiz NE et al. Acitretin. 2013 Sep-Oct Dermatol Ther pmid:24099069
Digiovanna JJ et al. Systemic retinoids in the management of ichthyoses and related skin types. 2013 Jan-Feb Dermatol Ther pmid:23384018
Davis SA et al. Acitretin prescribing patterns in women of childbearing potential. 2013 J Drugs Dermatol pmid:23884494
Ueo D et al. Late-onset Darier's disease due to a novel missense mutation in the ATP2A2 gene: a different missense mutation affecting the same codon has been previously reported in acrokeratosis verruciformis. 2013 J. Dermatol. pmid:23289714
Miyagaki T et al. Oral erosive lichen planus associated with thymoma treated with etretinate. 2013 Australas. J. Dermatol. pmid:23373893
Inoue T et al. Vitamin A treatment for psoriasis vulgaris in a dialysis patient. 2013 Am. J. Kidney Dis. pmid:24011973
Akasaka E et al. Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010. 2013 J. Dermatol. pmid:23330814
Nakamura S et al. Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate. 2012 Sep-Oct Eur J Dermatol pmid:22929532
Umezawa Y et al. Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years. 2012 Mar-Apr Pediatr Dermatol pmid:22409471
Vena GA and Cassano N The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs. 2012 Expert Opin Drug Metab Toxicol pmid:22594656
Yamamoto M et al. Case of epidermolytic ichthyosis (bullous congenial ichthyosiform erythroderma) with a novel L157P mutation in KRT10 complicated by hypercalcemia. 2012 J. Dermatol. pmid:22035476
Shin SY et al. Blood donors on teratogenic drugs and donor deferral periods in a clinical situation. 2012 Vox Sang. pmid:22211799
Yamamoto M et al. Severe generalized pustular psoriasis accompanied by bullae formation with increased serum vascular endothelial growth factor level. 2012 J. Dermatol. pmid:21767290
Tourlaki A et al. Genetically proven Mal de Meleda complicated by Bowen's disease of the sole. 2011 Mar-Apr Eur J Dermatol pmid:21382790
Gutierrez-Mazariegos J et al. Vitamin A: a multifunctional tool for development. 2011 Semin. Cell Dev. Biol. pmid:21693195
Wakamatsu K et al. Psoriasis verrucosa. 2010 J. Dermatol. pmid:21083712
Tsuji S et al. Case report: psoriatic erythroderma with bilateral osseous bridge across the acetabulum. 2010 Clin. Orthop. Relat. Res. pmid:19657703
Senba-Nakata K et al. Etretinate combined with low-dose prednisolone for an aged patient with adult T-cell leukaemia/lymphoma. 2010 Clin. Exp. Dermatol. pmid:19925487
Seishima M et al. Photoleukomelanoderma possibly caused by etretinate in a patient with psoriasis. 2010 Acta Derm. Venereol. pmid:20107735
Abbott RA and Griffiths WA Pityriasis rubra pilaris type 1 spontaneously resolving after 20 years. 2009 Clin. Exp. Dermatol. pmid:19309372
Lin MH et al. Sequential systemic retinoid and photodynamic therapy for multiple keratotic pigmented nodular basal cell carcinomas on the scalp. 2009 J. Dermatol. pmid:19712282
Ishida N et al. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy. 2009 Clin. Exp. Dermatol. pmid:19077103
Nakashima H et al. Cutaneous gamma/delta T-cell lymphoma treated with retinoid and narrowband ultraviolet B. 2009 Clin. Exp. Dermatol. pmid:19456763
Park HD et al. A fully validated HPLC method for the simultaneous determination of acitretin and etretinate in plasma and its application to a pharmacokinetic study in healthy Korean subjects. 2009 Int J Clin Pharmacol Ther pmid:19640355
Stosić-Grujicić S et al. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice. 2009 Mol. Immunol. pmid:19211146
Macbeth AE and Johnston GA Twenty-one years of oral retinoid therapy in siblings with nonbullous ichthyosiform erythroderma. 2008 Clin. Exp. Dermatol. pmid:17927786
Park HD et al. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions. 2008 Transfusion pmid:18657077
Liu X et al. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma. 2008 Cancer Chemother. Pharmacol. pmid:18465132
Ishiura N et al. A case of milia en plaque successfully treated with oral etretinate. 2007 Br. J. Dermatol. pmid:17927794
Goodemote P et al. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis? 2007 J Fam Pract pmid:17976342
Komatsu N et al. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy. 2007 Br. J. Dermatol. pmid:17459012
Saba NF et al. Moving toward bioadjuvant approaches to head and neck cancer prevention. 2007 Int. J. Radiat. Oncol. Biol. Phys. pmid:17848282
Halverstam CP et al. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature. 2006 Nov-Dec J Cutan Med Surg pmid:17241599
Mashiko M et al. Bacterial infection-induced generalized Hailey-Hailey disease successfully treated by etretinate. 2006 Clin. Exp. Dermatol. pmid:16309483
Kano Y et al. Dramatic improvement of psoriatic erythroderma after acute hepatitis: analysis of cytokine synthesis capability in peripheral blood T cells. 2006 Br. J. Dermatol. pmid:16882189
Katugampola RP and Finlay AY Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients. 2006 Br. J. Dermatol. pmid:16433796
Asano K et al. Fibrodysplasia ossificans progressiva-like condition in a cat. 2006 J. Vet. Med. Sci. pmid:17019075
Marquart JD et al. Human papillomavirus 57-induced extensive, recalcitrant cutaneous verrucae. 2006 J. Am. Acad. Dermatol. pmid:17052505
Okuyama R and Tagami H Psoriasis verrucosa in an obese Japanese man; a prompt clinical response observed with oral etretinate. 2006 J Eur Acad Dermatol Venereol pmid:17062076
Asano Y et al. Generalized granuloma annulare treated with short-term administration of etretinate. 2006 J. Am. Acad. Dermatol. pmid:16631959
Akiyama M et al. Compound heterozygous mutations including a de novo missense mutation in ABCA12 led to a case of harlequin ichthyosis with moderate clinical severity. 2006 J. Invest. Dermatol. pmid:16675967
Yanagi T et al. Epidermodysplasia verruciformis and generalized verrucosis: the same disease? 2006 Clin. Exp. Dermatol. pmid:16681585
Gordon KB and Ruderman EM The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach. 2006 J. Am. Acad. Dermatol. pmid:16488334
Inozume T et al. Successful use of etretinate for long-term management of a patient with cutaneous-type adult T-cell leukaemia/lymphoma. 2005 Br. J. Dermatol. pmid:16307674
Seishima M et al. Thrombocytopenia possibly induced by etretinate in a psoriatic patient. 2005 J. Dermatol. pmid:16361755
Ikeda T et al. The effects of vitamin A derivative etretinate on the skin of MRL mice. 2005 Lupus pmid:16130505
Yamamoto T et al. Evaluation of psoriatic patients with HCV infection. 2005 J. Dermatol. pmid:16361725
Bukhari IA Impetigo herpetiformis in a primigravida: successful treatment with etretinate. 2004 Jul-Aug J Drugs Dermatol pmid:15303793
Horikoshi M et al. Punctate palmoplantar keratoderma with pigmentary lesions on the dorsa of feet and ankles: successful treatment with a combination of low-dose oral etretinate and topical calcipotriol. 2004 J. Dermatol. pmid:15235186
Yamamoto T et al. Temporomandibular arthritis in a patient with psoriasis vulgaris under systemic etretinate therapy. 2004 Dermatology (Basel) pmid:15237278
De Graaf YG et al. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. 2004 Dermatol Surg pmid:15061851
Fujimura T et al. CCR4 Expression by atypical T cells in systemic pilotropic lymphoma: its behavior under treatment with interferon gamma, topical PUVA and systemic retinoid. 2004 Dermatology (Basel) pmid:15118371
Suzuki K et al. Localized Darier's disease of the scalp: successful treatment with oral etretinate. 2004 Dermatology (Basel) pmid:14730246
Launay F et al. [Sneddon-Wilkinson disease. Four cases report]. 2004 Rev Med Interne pmid:14744648
Ikeda T et al. The Vitamin A derivative etretinate improves skin sclerosis in patients with systemic sclerosis. 2004 J. Dermatol. Sci. pmid:14757285
Kobayashi H and Tagami H Functional properties of the surface of the vermilion border of the lips are distinct from those of the facial skin. 2004 Br. J. Dermatol. pmid:15030342
Peñas PF et al. Dermatologic treatment of cutaneous graft versus host disease. 2004 Am J Clin Dermatol pmid:15663337
Shimizu S et al. Dramatic efficacy of oral aromatic retinoid in long-standing hypertrophic lupus erythematosus. 2004 Acta Derm. Venereol. pmid:15844651
Fraunfelder FW and Fraunfelder FT Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension. 2004 J Neuroophthalmol pmid:15348987
Kato N et al. Ferguson Smith type multiple keratoacanthomas and a keratoacanthoma centrifugum marginatum in a woman from Japan. 2003 J. Am. Acad. Dermatol. pmid:14512932
Lebwohl M et al. Case studies in severe psoriasis: A clinical strategy. 2003 J Dermatolog Treat pmid:14578096
Foulc P et al. Prognostic factors in Sézary syndrome: a study of 28 patients. 2003 Br. J. Dermatol. pmid:14674891
Corazza M et al. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine. 2003 Dermatology (Basel) pmid:12771475
Sahin MT et al. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis? 2003 J Eur Acad Dermatol Venereol pmid:12705767
Liu Y et al. Sharing of the same embryogenic pathway in anorectal malformations and anterior sacral myelomeningocele formation. 2003 Pediatr. Surg. Int. pmid:12682745
Ogasawara Y et al. A case of multiple keratoacanthoma centrifugum marginatum: response to oral etretinate. 2003 J. Am. Acad. Dermatol. pmid:12582405
Hu W et al. Acrokeratoelastoidosis. 2002 Jul-Aug Pediatr Dermatol pmid:12220276
Schopf RE et al. A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. 2002 J. Invest. Dermatol. pmid:12164939
Kreiss C et al. Severe cholestatic hepatitis in a patient taking acitretin. 2002 Am. J. Gastroenterol. pmid:11922592
Fujii K et al. Short-term etretinate therapy for prurigo chronica multiformis. 2002 J. Dermatol. pmid:11990249
Budzyńska B et al. The epidermis mitochondria ultrastructure evaluation of the etretinate-treated white rat. 2002 Ann Univ Mariae Curie Sklodowska Med pmid:12898836
Qu ZX et al. Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis. 2001 Arch. Neurol. pmid:11176940
Krinitsyna YM et al. Ultrastructural and biosynthetic characteristics of epidermal cells in patients with psoriasis treated with antiproliferative drugs. 2001 Bull. Exp. Biol. Med. pmid:11713570
Schmutz JL et al. [Treatment with acitretin and alcohol drinking: a high risk combination]. 2001 Ann Dermatol Venereol pmid:11908183
Maier H and Hönigsmann H Assessment of acitretin-treated female patients of childbearing age and subsequent risk of teratogenicity. 2001 Br. J. Dermatol. pmid:11899131
Górnicki A and Gutsze A In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity. 2001 Eur. J. Pharmacol. pmid:11448476
Magis NL et al. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use. 2000 Oct-Nov Eur J Dermatol pmid:11056421
Knights KM et al. In vitro metabolism of acitretin by human liver microsomes: evidence of an acitretinoyl-coenzyme A thioester conjugate in the transesterification to etretinate. 2000 Biochem. Pharmacol. pmid:10874125
Hotard RS et al. Sex-specific differences in the treatment of severe psoriasis. 2000 J. Am. Acad. Dermatol. pmid:10727307
Morishima T and Ochiai T [Papillon-Lefèvre syndrome]. 2000 Ryoikibetsu Shokogun Shirizu pmid:11212727
Khatri ML et al. Epidermolytic hyperkeratosis (bullous ichthyosis). 2000 J Eur Acad Dermatol Venereol pmid:11204534
Bowman PH and Hogan DJ Ulcerated atrophic striae from etretinate. 2000 Cutis pmid:10826097
Siragusa M et al. A new family with Papillon-Lefèvre syndrome: effectiveness of etretinate treatment. 2000 Cutis pmid:10738634
Jones G et al. Interventions for psoriatic arthritis. 2000 Cochrane Database Syst Rev pmid:10796328
Kubota Y et al. Congenital anomalies in mice induced by etretinate. 2000 Eur J Pediatr Surg pmid:11034515
Grønhøj Larsen F et al. Acitretin is converted to etretinate only during concomitant alcohol intake. 2000 Br. J. Dermatol. pmid:11122016
Gijbels MJ et al. Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). 2000 Exp. Dermatol. pmid:11016856
Tanaka E et al. [A case of intestinal Behçet's disease with abnormal ossification complicated by myelodysplastic syndrome, symptoms revealed after the perforation of ileum ulcer]. 2000 Ryumachi pmid:11021176
Hongcharu W et al. Generalized lichen amyloidosis associated with chronic lichen planus. 2000 J. Am. Acad. Dermatol. pmid:10901719
Jones G et al. Interventions for psoriatic arthritis. 2000 Cochrane Database Syst Rev pmid:10908464
Yasuda H et al. Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review. 2000 Br. J. Dermatol. pmid:10886149
Kanoh H et al. Granulomatous nodule on vocal cord possibly induced by etretinate therapy. 2000 Br. J. Dermatol. pmid:10848772
Hashimoto K et al. Lamellar ichthyosis: response to etretinate with transglutaminase 1 recovery. 2000 Am J Dermatopathol pmid:10871075
Koide D et al. Computerized reminders to monitor liver function to improve the use of etretinate. 2000 Int J Med Inform pmid:10708252
Koreeda T et al. Inhibitory effect of retinoid on esophageal carcinogenesis in rats induced by N-nitroso-N-methylbutylamine in relation to cellular retinoic acid-binding protein. 1999 Sep-Oct Anticancer Res. pmid:10628365
Ozawa A et al. Treatments of generalized pustular psoriasis: a multicenter study in Japan. 1999 J. Dermatol. pmid:10209919
Orfanos CE Treatment of psoriasis with retinoids: present status. 1999 Cutis pmid:10582161
Brodell RT and Williams L A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. 1999 Postgrad Med pmid:10608962